Patient P-02446
Synthetic patientMETA-24 · Day 168 · 55–64 · F · baseline S04Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Deteriorating
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Declining
Discontinuation risk
21%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S04
- Day 17 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 17.
Primary contributors, last 14 days
- Toxicity+12
- Nutritional resilience-9
- Treatment adherence-3
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable85 min
improving · +3.4 vs previous 14 d
Sleep duration
Wearable7.9 h
stable · -0.2 vs previous 14 d
Energy level
Daily log6.2/10
worsening · -0.4 vs previous 14 d
Steps
Wearable8,381
improving · +382 vs previous 14 d
GI burden
Companion21/100
worsening · +3.8 vs previous 14 d
Adherence
Companion83.9 %
stable · +1.6 vs previous 14 d
Sleep quality
Wearable65.2/100
worsening · -5.7 vs previous 14 d
Glucose, CGM daily mean
CGM130 mg/dL
stable · +3.9 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards restoration · 63 from the failing basin, 43 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More histamineGI -2.2 next day on high-intake days · n 15
- More proteinGI -2.1 next day on high-intake days · n 22
Would not help
- BR-03 Behavioural Recommendationonly 27% improved among 11 similar
- Keep ultra-processed lowGI +1.6 next day on high-intake days · n 21
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Histamine load-2.2supporter · 67%
- Protein-2.1supporter · 77%
- Ultra-processed food+1.6detractor · 58%
- Insoluble fibre+1.2no signal · 37%
- Simple carbohydrates-0.9no signal · 26%
- Dietary fat load-0.5no signal · 18%
- Caffeine-0.2no signal · 15%
- Alcohol-0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↑45
- DNAIL6 -174 variant raises baseline inflammatory tone
- MicrobiomeBacteroides fragilis expansion
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
DNA
Fictional pharmacogenomic panel
- IL6 -174 G/CHigher inflammatory tone
- CYP2D6 Normal metabolizerExpected exposure
- GLP1R rs6923761 AAltered receptor sensitivity
Microbiome
Shannon diversity 3.7 · butyrate capacity 71/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 65 ms
- Sleep
- 7.7 h
- Steps
- 9,063
- Resting HR
- 71 bpm
Daily log: GI score 21, nutritional resilience 62, adherence 84.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02698 | 26% | S06 | ME-01 | improved | 71 |
| P-02214 | 25% | S08 | SC-12 | no change | 69 |
| P-02293 | 26% | S15 | HY-01 | no change | 68 |
| P-02090 | 25% | S04 | — | — | 68 |
| P-02658 | 27% | S04 | — | — | 66 |
| P-02109 | 25% | S04 | — | — | 66 |
| P-02095 | 26% | S08 | — | — | 66 |
| P-02286 | 25% | S10 | — | — | 65 |
| P-02617 | 26% | S03 | — | — | 64 |
| P-02044 | 27% | S03 | — | — | 64 |
| P-02483 | 27% | S06 | BR-03 | no change | 64 |
| P-02579 | 27% | S09 | — | — | 64 |